Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$32.46 - $40.48 $7,530 - $9,391
-232 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$33.61 - $49.95 $7,797 - $11,588
232 New
232 $8,000
Q3 2020

Nov 12, 2020

SELL
$27.01 - $40.26 $540 - $805
-20 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$27.75 - $43.44 $555 - $868
20 New
20 $1,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $433M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Sowell Financial Services LLC Portfolio

Follow Sowell Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sowell Financial Services LLC with notifications on news.